Search results
Results from the WOW.Com Content Network
This page was last edited on 3 February 2024, at 22:53 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.
Although no clinical development took place, Axovant held its IPO in June 2015 and raised $315 million, [4] the largest biotech IPO ever, [9] based on new phase IIB trials that were more promising. [10] The lock-up period against reselling stock was reduced to an unusually short 90 days for hedge funds that showed interest in the IPO. [11]
You can often tell the health of the stock market by the number and performance of initial public offerings, or IPOs. As 2022 has seen a bear market in the major averages, it's not surprising at ...
Leading U.S. exchange for healthcare, technology and biotech IPOs: Nasdaq maintained its strong track record in the healthcare, technology and biotech sectors. Further, 100% of eligible biotech companies listed on Nasdaq, including CG Oncology, the largest biotech listing so far this year.
The FDA approval machinery worked overtime in May, with several new labelings, original approvals and new molecule approvals coming through in the month. The month saw the approval of two new ...
Those figures rose markedly from the 2022 doldrums of 71 IPOs and just $7.7 billion raised. But 2022 was the worst year for IPOs since at least 2010, ...
In order to enter these new fields, Cetus raised $108 million in an initial public offering (IPO) in 1981, the largest IPO to that date. Its first large development project, in conjunction with Triton Biosciences, was the successful cloning , expression, modification, and production of beta-interferon .
For premium support please call: 800-290-4726 more ways to reach us